Is the Wegovy pill as effective as the injections?
Wegovy (semaglutide) does come in a pill form. In December of 2025, the Food and Drug Administration (FDA) approved Wegovy as an oral tablet.
Wegovy injections and tablets contain the same active ingredient, semaglutide. Both forms of Wegovy are FDA-approved for:
Unlike the injections, the Wegovy tablet is not approved for weight management in children ages 12 or older, or for the treatment of metabolic dysfunction-associated steatohepatitis (MASH).
The day-to-day difference between taking a Wegovy tablet versus having an injection matters for some people. A daily tablet can feel more routine, while a weekly injection may be simpler for some people if adhering to daily medications is challenging.
If needed, switching between Wegovy injection and the 25 mg tablet is possible, with medical supervision, but taking both forms of the drug at the same time is not recommended.
Wegovy has a boxed warning for the risk of thyroid cancer. A boxed warning is the most serious warning from the FDA. This article summarizes key information about Wegovy and does not include all details from the full prescribing information.
In most cases, it can be. At their full maintenance doses, average semaglutide levels in the body are similar between the Wegovy 25 mg daily tablet and the 2.4 mg weekly injection in adults. This suggests the body is exposed to comparable amounts of the active ingredient in Wegovy once you’ve reached the target dose.
Both Wegovy tablets and injections have the same mechanism of action and are expected to work similarly. However, there are not enough clinical trials or studies comparing head-to-head tablets and injections to prove that one works faster or more effectively than the other.
Side effects of Wegovy are also similar for the tablet and the injection because it’s the same drug, only in different administration forms. These effects may include vomiting, nausea, or diarrhea.
In clinical trials, severe gastrointestinal side effects and gallstones occurred in a small percentage of people taking Wegovy injections and Wegovy tablets.
For adults using Wegovy for weight loss or heart risk reduction, both the tablet and the injection are approved options. For children ages 12 and older with obesity or for people with MASH, the Wegovy injection is the only FDA-approved option.
The biggest difference between taking Wegovy as a tablet or as an injection is how often you take it, how it fits into your routine, and which specific FDA-approved uses apply to you.
If you’re thinking about starting Wegovy or switching forms, the next step is to review your options with a licensed clinician.
They may ask you to share your health history, including all the other medications you take, and will discuss whether you prefer a weekly shot or a daily pill. Together, you can decide which Wegovy formulation best suits your goals and medical needs.
Disclaimer: While Medical News Today strives for factual, comprehensive, and current information, this article is not a substitute for a licensed healthcare professional’s expertise. Always consult a doctor before taking or discontinuing any medication. Drug information is subject to change and may not cover all uses, directions, precautions, warnings, interactions, reactions, or adverse effects. The lack of a warning does not guarantee a drug’s safety, effectiveness, or appropriateness for all patients or specific uses. Learn more about our approach to content integrity.